The pharmaceutical Outsourcing Series consistist of the following Contract Research and Contract Manufacturing titles...

Contract Research

Optimizing Partnerships with Contract Organizations
This report uses case studies of partnering strategies to highlight the most effective methods of reducing risk, in addition to evaluating the emerging trends and offshore outsourcing opportunities of markets such as Eastern Europe, China, India and Latin America.
Table of contents | Brochure | More information

The CRO Market Outlook
This report profiles the major international CRO players providing market share data and detailed analysis on current and future R&D spend.
Table of contents | Brochure | More information

Patient Recruitment and Retention in Clinical Trials
On a global basis, the drug development process is becoming increasingly complex, time consuming and expensive.
Table of contents | Brochure | More information

Winning R&D Productivity Strategies
Use this report to identify key areas of growth, effective strategies and innovative technologies to improve lead generation, attrition rates and return on investment from your portfolio.
Table of contents | Brochure | More information

Pharmaceutical Outsourcing Strategies
Over the last decade outsourcing has become an important strategic issue for pharmaceutical companies; rising pressure to reduce costs and time-to-market has led to outsourcing not only of traditional non-core functions such as manufacturing and clinical trials, but also increasingly of technically demanding areas such as drug discovery and biotech R&D.
Table of contents | Brochure | More information

Drug Development Opportunities in China
This report provides a comprehensive review of China’s drug development industry, both in terms of expanding domestic markets and the country’s role as a third-party provider of outsourced global drug developments.
Table of contents | Brochure | More information

Lead Optimization Strategies
More and more companies are resorting to streamlining their internal programs, both pre-clinical and clinical, to improve productivity and the cost-effectiveness of bringing drugs to the market.
Table of contents | Brochure | More information

Drug Safety in the Post-Vioxx Era
Develop a tighter drug safety strategy by analyzing nine case studies describing safety issues encountered by pharmaceutical companies and examine the predictions for the future of drug safety regulation in the US and EU.
Table of contents | Brochure | More information

The Future of Biosimilars
This report examines the current market and regulatory environment for biosimilars in Europe, India, China and the US, whilst identifying the trends that will shape future market development.
Table of contents | Brochure | More information

Contract Manufacturing

Contract Manufacturing Strategies: Market developments, technology transfer and key success factors
Contract Manufacturing Strategies’ is a new report published by Business Insights that explores the future of the contract manufacturing market with a detailed analysis of emerging drivers and restraints, business models and production strategies. The potential benefits and risks of contract manufacturing are assessed and the key strategies for effective CMO selection and successful relationship management are identified.
Table of contents | Brochure | More information

Biomanufacturing Strategies
Use this report to identify the key criteria involved in CMO selection, compare the expansion strategies and capacity shares of leading players and analyse the growth drivers shaping the future of biomanufacturing.
Table of contents | Brochure | More information

Pharmaceutical Growth Opportunities in Brazil, Russia, India and China
Benchmark your growth strategies against the top pharmaceutical companies operating in the BRIC markets, align your portfolio with future market opportunity and identify lucrative partnering opportunities to ensure you maximize the potential from these promising markets with this report.
Table of contents | Brochure | More information

The Biotechnology Market Outlook
This report will help you to evaluate the market opportunity that exists and outlines the key drivers and resistors to growth, providing best-practice growth strategies for early and late stage drug developers and integrated biotech companies.
Table of contents | Brochure | More information

The Biogenerics Market Outlook
This report identifies strategies for biogenerics success and evaluates the obstacles that need to be overcome in order to capture a share of this highly profitable, untapped market.
Table of contents | Brochure | More information

The Future of Monoclonal Antibody Therapeutics
This report profiles the major international CRO players providing market share data and detailed analysis on current and future R&D spend.
Table of contents | Brochure | More information